Figure 1.
Introduction of FE11 γδTCR in αβT cells can reestablish tumor cell recognition of clone FE11 cells. (A) To assess tumor reactivity, clone FE11 cells were incubated with SW480 or EBV-LCL tumor target cells. IFN-γ secretion was measured by ELISPOT. Healthy PBMCs served as negative control targets. (B) The TCR-γ and -δ chains of clone FE11 cells were sequenced and retrovirally transduced into αβT cells. Transfer of γδTCR-mediated tumor reactivity was tested by coincubating mock- (left) or γδTCR-transduced (right) T cells with indicated target cells in an IFN-γ ELISPOT. (C) The effect of blocking with FE11-like hybridoma supernatant on the recognition of SW480 and LCL-TM cells by FE11 γδTCR–transduced T cells. (D) LABScreen Single Antigen HLA class I beads were incubated with antibodies purified from hybridoma 6 (mAb6) or from hybridoma 12 (mAb12) and secondary α-mIgG-PE measured using Luminex. Error bars represent the standard deviation (SD; n ≥ 1). MFI, mean fluorescence intensity.